Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1. (2020)

First Author: Crowther MD

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41590-019-0578-8

PubMed Identifier: 31959982

Publication URI: http://europepmc.org/abstract/MED/31959982

Type: Journal Article/Review

Volume: 21

Parent Publication: Nature immunology

Issue: 2

ISSN: 1529-2908